Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cellular activity, matrix proteins, and aging bone.

J D Termine1

  • 1Bone Research Branch, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland 20892.

Experimental Gerontology
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro.

Bone·2002
Same author

Treatment and prevention of osteoporosis: future directions.

Journal of the South Carolina Medical Association (1975)·2001
Same author

Post-menopausal women and osteoporosis: available choices for maintenance of skeletal health.

Maturitas·1999
Same author

Molecular determinants of tissue selectivity in estrogen receptor modulators.

Proceedings of the National Academy of Sciences of the United States of America·1998
Same author

Estrogen and raloxifene stimulate transforming growth factor-beta 3 gene expression in rat bone: a potential mechanism for estrogen- or raloxifene-mediated bone maintenance.

Endocrinology·1996
Same author

The X-chromosomal human biglycan gene BGN is subject to X inactivation but is transcribed like an X-Y homologous gene.

Human genetics·1995
Same journal

A comparative study reveals distinct patterns of resting-state activity in tinnitus and chronic pain.

Experimental gerontology·2026
Same journal

Letter to the editor: Bidirectional associations between metabolic syndrome and epigenetic age acceleration.

Experimental gerontology·2026
Same journal

Integrated single-cell and Mendelian randomization analyses identify aging-induced brain endothelial SPARCL1 deficiency as a key driver of vascular dementia.

Experimental gerontology·2026
Same journal

Effects of different intensities of aerobic exercise on intestinal permeability and inflammatory response in older adults: Randomized clinical trial.

Experimental gerontology·2026
Same journal

Gut microbial signature for frailty discrimination: a metagenomic meta-analysis of 28 independent cohorts.

Experimental gerontology·2026
Same journal

The joint association of biological aging and dietary oxidative balance score with cardiometabolic multimorbidity among U.S. older adults.

Experimental gerontology·2026
See all related articles

Bone extracellular matrix proteins, like osteopontin, degrade with age, potentially impairing bone regeneration. Reduced osteonectin production in aged bone cells warrants further investigation for its role in bone health.

Area of Science:

  • Bone biology
  • Extracellular matrix composition
  • Aging and bone health

Background:

  • Bone's extracellular matrix (ECM) contains local and exogenous proteins, including growth factors crucial for bone regeneration.
  • Osteoblasts' bone-forming capacity diminishes with age, contrasting with higher fetal osteoblast activity.
  • ECM proteins like fibronectin and osteopontin influence cell development but degrade with aging, potentially affecting bioactivity.

Purpose of the Study:

  • To investigate the role of age-related changes in bone extracellular matrix proteins.
  • To explore the impact of protein degradation on bone cell function in aged individuals.
  • To examine osteonectin production in aged bone cells as a potential marker for bone health.

Main Methods:

  • Analysis of bone extracellular matrix protein composition.

Related Experiment Videos

  • In vitro studies comparing fetal and adult osteoblast function.
  • Assessment of age-related degradation of cell attachment proteins.
  • Evaluation of osteonectin production in aged bone cells.

    • Main Results:

    • Bone ECM proteins, including growth factors and cell attachment proteins, are vital for bone regeneration.
    • Aging is associated with reduced osteoblast function and degradation of ECM proteins like osteopontin.
    • Osteonectin, crucial for growth and proliferation, shows reduced production in aged bone cells.

    Conclusions:

    • Age-related degradation of bone ECM proteins may impair bone cell function and regeneration.
    • Reduced osteonectin production in aged bone cells is a significant finding requiring further research.
    • Understanding these molecular changes is key to addressing age-related bone health decline.